CERTARA INC (CERT) Stock Price, Quote, News and Overview
NASDAQ:CERT - Nasdaq - US15687V1098 - Common Stock - Currency: USD
CERT Quote, Performance and Key Statistics
11.73
+0.11 (+0.95%)
The current stock price of CERT is 11.73 USD. In the past month the price decreased by -13.81%. In the past year, price decreased by -39.41%.
CERT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 37.34 | 40.07B | ||
| DOCS | DOXIMITY INC-CLASS A | 49.98 | 12.01B | ||
| WAY | WAYSTAR HOLDING CORP | N/A | 6.44B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 13.97 | 1.77B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.59B | ||
| SDGR | SCHRODINGER INC | N/A | 1.54B | ||
| PHR | PHREESIA INC | N/A | 1.38B | ||
| EVH | EVOLENT HEALTH INC - A | 13.62 | 1.05B | ||
| HSTM | HEALTHSTREAM INC | 49.74 | 999.02M | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 989.63M | ||
| SLP | SIMULATIONS PLUS INC | 70.58 | 567.14M | ||
| DH | DEFINITIVE HEALTHCARE CORP | 8.14 | 434.03M |
Related stock screener links
About CERT
Company Profile
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. The company is headquartered in Radnor, Pennsylvania and currently employs 1,338 full-time employees. The company went IPO on 2020-12-11. The firm accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. The company delivers software products and technology-driven services to customers to efficiently carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services are underpinned by technologies such as regulatory submissions software, natural language processing and Bayesian analytics. The company also develops scientific informatics software products used by the life sciences industry for in-silico research. The company develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 66 countries.
Company Info
CERTARA INC
4 Radnor Corporate Center, Suite 350
Radnor PENNSYLVANIA 08540 US
CEO: William F. Feehery
Employees: 1338
Company Website: https://www.certara.com/
Investor Relations: https://ir.certara.com/
Phone: 14152378272
CERTARA INC / CERT FAQ
What is the stock price of CERTARA INC today?
The current stock price of CERT is 11.73 USD. The price increased by 0.95% in the last trading session.
What is the ticker symbol for CERTARA INC stock?
The exchange symbol of CERTARA INC is CERT and it is listed on the Nasdaq exchange.
On which exchange is CERT stock listed?
CERT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CERTARA INC stock?
18 analysts have analysed CERT and the average price target is 14.99 USD. This implies a price increase of 27.83% is expected in the next year compared to the current price of 11.73. Check the CERTARA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CERTARA INC worth?
CERTARA INC (CERT) has a market capitalization of 1.89B USD. This makes CERT a Small Cap stock.
How many employees does CERTARA INC have?
CERTARA INC (CERT) currently has 1338 employees.
What are the support and resistance levels for CERTARA INC (CERT) stock?
CERTARA INC (CERT) has a support level at 11.72 and a resistance level at 12.32. Check the full technical report for a detailed analysis of CERT support and resistance levels.
Is CERTARA INC (CERT) expected to grow?
The Revenue of CERTARA INC (CERT) is expected to grow by 9.64% in the next year. Check the estimates tab for more information on the CERT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CERTARA INC (CERT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CERT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CERT, evaluating the profitability, health, valuation and growth aspects
- CERTARA INC (CERT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CERTARA INC (CERT) Sales and EPS estimates to see what analysts future expectations are.
- CERTARA INC (CERT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CERTARA INC (CERT) Insider and Institutional Ownership to learn about the owners and their transactions.
- CERTARA INC (CERT) Stock Chart to make your own analysis
- CERTARA INC (CERT) Latest news and press-releases to stay up to date.
Does CERTARA INC (CERT) stock pay dividends?
CERT does not pay a dividend.
When does CERTARA INC (CERT) report earnings?
CERTARA INC (CERT) will report earnings on 2025-05-05, after the market close.
What is the Price/Earnings (PE) ratio of CERTARA INC (CERT)?
The PE ratio for CERTARA INC (CERT) is 26.07. This is based on the reported non-GAAP earnings per share of 0.45 and the current share price of 11.73 USD. Check the full fundamental report for a full analysis of the valuation metrics for CERT.
What is the Short Interest ratio of CERTARA INC (CERT) stock?
The outstanding short interest for CERTARA INC (CERT) is 5.11% of its float. Check the ownership tab for more information on the CERT short interest.
CERT Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CERT. When comparing the yearly performance of all stocks, CERT is a bad performer in the overall market: 77.77% of all stocks are doing better.
CERT Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CERT. The financial health of CERT is average, but there are quite some concerns on its profitability.
CERT Financial Highlights
Over the last trailing twelve months CERT reported a non-GAAP Earnings per Share(EPS) of 0.45. The EPS increased by 2.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.77% | ||
| ROE | -1.14% | ||
| Debt/Equity | 0.28 |
CERT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to CERT. The Buy consensus is the average rating of analysts ratings from 18 analysts.
For the next year, analysts expect an EPS growth of 12.83% and a revenue growth 9.64% for CERT